News about "antibody-based treatments"

Harbour BioMed and Kelun-Biotech Secure National Medical Products Administration IND Approval for Novel Bispecific Antibody in Atopic Dermatitis

Harbour BioMed and Kelun-Biotech Secure National Medical Products Administration IND Approval for Novel Bispecific Antibody in Atopic Dermatitis

National Medical Products Administration approves IND application for HBM7575/SKB575, a long-acting bispecific antibody developed by Harbour BioMed and Kelun-Biotech for treating atopic dermatitis.

Antibody-based Treatments | 10/03/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members